<- Go home

Added to YB: 2023-01-30

Pitch date: 2023-01-30

HZNP [bullish]

Horizon Therapeutics Public Limited Company

+5.61%

current return

Author Info

No bio for this author

Company Info

Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases.

Market Cap

$26.6B

Pitch Price

$110.12

Price Target

N/A

Dividend

N/A

EV/EBITDA

39.41

P/E

61.85

EV/Sales

7.37

Sector

Biotechnology

Category

N/A

Show full summary:
HORIZON THERAPEUTICS PUB LTD HZNP

A summary for this pitch has not been created yet.

Read full article (0 min)